Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia.

Barth BM, Wang W, Toran PT, Fox TE, Annageldiyev C, Ondrasik RM, Keasey NR, Brown TJ, Devine VG, Sullivan EC, Cote AL, Papakotsi V, Tan SF, Shanmugavelandy SS, Deering TG, Needle DB, Stern ST, Zhu J, Liao J, Viny AD, Feith DJ, Levine RL, Wang HG, Loughran TP Jr, Sharma A, Kester M, Claxton DF.

Blood Adv. 2019 Sep 10;3(17):2598-2603. doi: 10.1182/bloodadvances.2018021295. No abstract available.

2.

Combinatorial Efficacy of Quercitin and Nanoliposomal Ceramide for Acute Myeloid Leukemia.

McGill CM, Brown TJ, Fisher LN, Gustafson SJ, Dunlap KL, Beck AJ, Toran PT, Claxton DF, Barth BM.

Int J Biopharm Sci. 2018;1(1). pii: 106. doi: 10.31021/ijbs.20181106. Epub 2018 Jan 31.

3.

Epigenetics and Sphingolipid Metabolism in Health and Disease.

Wang W, Toran PT, Sabol R, Brown TJ, Barth BM.

Int J Biopharm Sci. 2018 Oct;1(2). pii: 105. doi: 10.31021/ijbs.20181105. Epub 2018 Jan 22.

4.

Therapeutic Effect of Blueberry Extracts for Acute Myeloid Leukemia.

McGill CM, Brown TJ, Cheng YY, Fisher LN, Shanmugavelandy SS, Gustafson SJ, Dunlap KL, Lila MA, Kester M, Toran PT, Claxton DF, Barth BM.

Int J Biopharm Sci. 2018 Jan;1(1). pii: 102. Epub 2018 Jan 2.

5.

Labeling native bacterial RNA in live cells.

Toran P, Smolina I, Driscoll H, Ding F, Sun Y, Cantor CR, Broude NE.

Cell Res. 2014 Jul;24(7):894-7. doi: 10.1038/cr.2014.47. Epub 2014 Apr 15. No abstract available.

6.

The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression.

Schmidt PJ, Toran PT, Giannetti AM, Bjorkman PJ, Andrews NC.

Cell Metab. 2008 Mar;7(3):205-14. doi: 10.1016/j.cmet.2007.11.016.

Supplemental Content

Loading ...
Support Center